GSK's R&D chief is making bets.
GSK's R&D chief is making bets.
Takeda will issue $35 billion in new stock.
Takeda will issue $35 billion in new stock.
Prices on 100 medications are going up.
Prices on 100 medications are going up.
It's the largest-ever international takeover by any Japanese company, at a ...
It's the largest-ever international takeover by any Japanese company, at a value of $62 billion.
Pfizer stock was down more than 4%, while Merck fell 2% despite beating pro...
Pfizer stock was down more than 4%, while Merck fell 2% despite beating profit expectations.
AveXis's main drug treats spinal muscular atrophy (SMA), a degenerative gen...
AveXis's main drug treats spinal muscular atrophy (SMA), a degenerative genetic condition.
The deal that could reshape the pharmacy and health insurance industries
The deal that could reshape the pharmacy and health insurance industries
